Dr. Prasad follows a personalised approach to cancer care, combining
detailed evaluation with appropriate chemotherapy, immunotherapy,
targeted treatment, cell therapy and transplantation when clinically
indicated. His approach focuses on evidence-based treatment,
multidisciplinary care and clear communication with patients and
families.
Dr. Prasad Narayanan's Oncology Treatments
Comprehensive medical treatment and management of solid tumours and
other cancers using appropriate systemic therapies.
Specialist management of blood cancers and other hematological
malignancies.
Stem cell and bone marrow transplantation for appropriately selected
patients with blood cancers and other serious conditions.
Advanced cancer treatment that uses the patient's immune system to
help recognise and fight cancer cells.
Advanced cellular treatment approaches for selected cancers and
hematological conditions.
Individualised cancer treatment based on tumour characteristics,
molecular findings and the patient's clinical condition.
Medical management of breast cancer using chemotherapy, targeted
therapy, hormonal treatment, immunotherapy or other appropriate
options.
Comprehensive medical oncology care for selected lung cancer
conditions and stages.
Systemic cancer treatment and multidisciplinary management for
selected head and neck malignancies.
Medical oncology management of colon and rectal cancers using
appropriate systemic treatment protocols.
Specialist medical management of cancers affecting the digestive
system.
Medical oncology care for selected cancers affecting the female
reproductive system.
Medical management of leukemia, lymphoma, myeloma and other
hematological malignancies.
Specialist evaluation and systemic treatment for acute and chronic
forms of leukemia.
Medical management of Hodgkin and non-Hodgkin lymphoma using
appropriate systemic treatment approaches.
Comprehensive medical management of multiple myeloma using
appropriate systemic and supportive treatment.
Use of anti-cancer medicines to destroy or control cancer cells as
part of an individualised treatment plan.
Cancer treatment using medicines designed to act on specific
molecular or biological features of cancer cells.
Systemic treatment that blocks or modifies hormone activity in
selected hormone-sensitive cancers.
Autologous and allogeneic stem cell transplantation for appropriately
selected patients with hematological malignancies and other
conditions.